Shanghai Haohai Biological Technology Co., Ltd. (FRA:5HB)

Market Cap	1.01B -35.5%
Revenue (ttm)	297.88M -8.7%
Net Income	30.57M -40.3%
EPS	0.13 -40.0%
Shares Out	n/a
PE Ratio	33.15
Forward PE	n/a
Dividend	0.12 (5.23%)
Ex-Dividend Date	Sep 5, 2025

Volume	n/a
Average Volume	n/a
Open	2.280
Previous Close	2.280
Day's Range	2.280 - 2.280
52-Week Range	2.280 - 3.240
Beta	n/a
RSI	24.90
Earnings Date	Apr 24, 2026

About FRA:5HB

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in Mainland China, Europe, the United States, and internationally. The company offers ophthalmic implants, assistive devices, and medical devices; medical optical instruments, including intraocular lenses, endoscopic equipment, ophthalmic surgical instruments, and other ophthalmic medical products; hyaluronic acid and chitosan; and electronic instruments, such as semiconductors, optoelectronics, lasers, radio frequ...

• Industry: Pharmaceutical Preparations
• Founded: 2007
• Employees: 2,156
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 5HB

Financial Performance

In 2025, FRA:5HB's revenue was 2.45 billion, a decrease of -8.71% compared to the previous year's 2.68 billion. Earnings were 251.01 million, a decrease of -40.30%.

Financial numbers in CNY